Preferred Label : ibalizumab;

MeSH note : a monoclonal antibody, TNX-355, prevents entry of human immunodeficiency virus (HIV) into the host cell. TNX-355 binds to the CD4 receptor on the cell's surface, an entry gate for infection, preventing viral entry and thereby blocking infection.;

CISMeF synonym : TMB-355; Hu-5A8; TNX-355;

Is substance : O;

UNII : LT369U66CE;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-acces-derogatoire/trogarzo-200-mg-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
Trogarzo
ibalizumab
drug information
multiresistant HIV-1 infection
hiv infections
HIV-1
drug resistance, multiple, viral
adult
anti-hiv agents
infusions, intravenous
Product containing only ibalizumab in parenteral dose form (medicinal product form)
ibalizumab

---
https://www.has-sante.fr/jcms/p_3184445/fr/trogarzo
2020
false
false
false
France
insurance, health, reimbursement
treatment outcome
ibalizumab
ibalizumab
ibalizumab
anti-hiv agents
hiv infections
HIV-1
adult
drug resistance, multiple, viral
infusions, intravenous
multiresistant HIV-1 infection
evaluation of the transparency committee
antibodies, monoclonal
antibodies, monoclonal

---
https://www.ema.europa.eu/en/medicines/human/EPAR/trogarzo
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
ibalizumab
ibalizumab
adult
hiv infections
anti-hiv agents
anti-hiv agents
ibalizumab
infusions, intravenous
CD4 Antigens
product surveillance, postmarketing
drug therapy, combination
aged
pregnancy
breast feeding
drug evaluation, preclinical
multiresistant HIV-1 infection
antibodies, monoclonal
antibodies, monoclonal

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.